Skip to Main Content

Paper Details

Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.
Circulation
0
2023
Canagliflozin, Dapagliflozin, Glucose, Heart Failure, Patient, Patients, SGLT2i, SGLT2is, Sodium, Sodium-, Sodium-Glucose Cotransporter 2, Sodium-glucose cotransporter 2, glucose, heart failure, participants, patient, patients
Author NameAffiliation
John A SpertusSaint Luke's Mid America Heart Institute and University of Missouri-Kansas City (K.G.
John A SpertusSaint Luke's Mid America Heart Institute and University of Missouri-Kansas City (K.G.
Mikhail KosiborodSaint Luke's Mid America Heart Institute and University of Missouri-Kansas City (K.G.
  • 1 - 3

Datasets

Release 1.2